Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-04-27 Conversion |
2021-04-29 9:10 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
39,725,922 | $0 | 349,674 (Indirect) |
View |
2021-04-27 Conversion |
2021-04-29 9:10 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
101,456 | $13.5 | 349,674 (Indirect) |
View |
2021-04-22 Other |
2021-04-26 6:24 pm |
N/A 2021-12-31 |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
1,359,799 | $0 | 1,359,799 (Indirect) |
View |
Ownership |
2021-04-22 9:30 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
0 | $0 | 2,208,333 (Indirect) |
View |
2021-02-09 Conversion |
2021-02-09 3:37 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
3,414,343 | $0 | 150,000 (Indirect) |
View |
2021-02-09 Exercise |
2021-02-09 3:37 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
64,319 | $0.07 | 150,000 (Indirect) |
View |
2021-02-09 Exercise |
2021-02-09 3:37 pm |
N/A 2028-07-26 |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
64,319 | $0 | 150,000 (Indirect) |
View |
2021-02-09 Conversion |
2021-02-09 3:08 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner |
3,426,240 | $0 | 357,353 (Indirect) |
View |
Ownership |
2021-02-04 7:33 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC 10% Owner |
0 | $0 | 3,521,517 (Indirect) |
View |
Ownership |
2021-02-04 5:05 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
0 | $0 | 2,200,133 (Indirect) |
View |
2020-10-20 Conversion |
2020-10-20 4:59 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
2,997,030 | $0 | 430,372 (Indirect) |
View |
Ownership |
2020-10-15 5:17 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
0 | $0 | 2,997,030 (Indirect) |
View |